Huoluo Pills

Developed for: rheumatoid arthritis
Investigated by: Affiliated Hospital of Liaoning University of Traditional Chinese Medicine · Affiliated Hospital of Shandong University of Traditional Chinese Medicine · Beijing Leadingpharm Medicine Technology Development · Institute of Science, Beijing Tongrentang Co., Ltd. · Shaanxi Hospital of Traditional Chinese Medicine · Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
+4 more
· The First Affiliated Hospital of Henan university of CM · The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine · Wangjing Hospital, China Academy of Chinese Medical Sciences · Xi'an No.5 Hospital

2026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT07115641	Aug 2025 → May 2026 overdue	rheumatoid arthritis	Wangjing Hospital, China Academy of Chinese Medical Sciences	Not yet recruiting	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Huoluo Pills	ClinicalTrials.gov intervention name — accepted as the source's own label NCT07115641 ↗
Route	Oral	“Orally take 1 pill once, twice a day” NCT07115641 ↗